AVeta GSM Device
Genitourinary Syndrome of Menopause (GSM) / Vaginal Atrophy
Key Facts
About AVeta Medical
AVeta Medical is a clinical-stage medical device company targeting the vast, underserved market of genitourinary syndrome of menopause (GSM). Its lead product is a novel, non-hormonal device designed to stimulate the body's natural wound-healing processes to restore vaginal tissue moisture and health, offering immediate and long-lasting symptom relief. The company has secured significant non-dilutive funding, including a €2.5M EIC Accelerator grant, and is progressing through clinical development with a First-in-Human trial underway and FDA/CE regulatory pathways in sight. AVeta aims to address a condition affecting hundreds of millions of women globally, where current hormonal treatments are often avoided or contraindicated.
View full company profile